The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Conservation of the Chk1 Checkpoint Pathway in Mammals: Linkage of DNA Damage to Cdk Regulation Through Cdc25
Abstract
In response to DNA damage, mammalian cells prevent cell cycle progression through the control of critical cell cycle regulators. A human gene was identified that encodes the protein Chk1, a homolog of the Schizosaccharomyces pombe Chk1 protein kinase, which is required for the DNA damage checkpoint. Human Chk1 protein was modified in response to DNA damage. In vitro Chk1 bound to and phosphorylated the dual-specificity protein phosphatases Cdc25A, Cdc25B, and Cdc25C, which control cell cycle transitions by dephosphorylating cyclin-dependent kinases. Chk1 phosphorylates Cdc25C on serine-216. As shown in an accompanying paper by Peng et al . in this issue, serine-216 phosphorylation creates a binding site for 14-3-3 protein and inhibits function of the phosphatase. These results suggest a model whereby in response to DNA damage, Chk1 phosphorylates and inhibits Cdc25C, thus preventing activation of the Cdc2–cyclin B complex and mitotic entry.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The phosphorylation of Chk1 enhances Chk1’s kinase activity, which in turn phosphorylates downstream substrates (e.g., Cdc25, BLM, and FANCD2/FANCE) and facilitates cell cycle arrest and DNA damage repair [91–93].”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [91]
Citations
Cites
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Self-citationCell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,050
Self-citationPeng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Self-citationRadiation-induced cell cycle arrest compromised by p21 deficiency
Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J. (1995) · Nature · doi:10.1038/377552a0 · Cited by 1,242
Wodarz, A., Hinz, U., Engelbert, M., & Knust, E. (1995) · Cell · doi:10.1016/0092-8674(95)90053-5 · Cited by 661
Enoch, T., & Nurse, P. (1990) · Cell · doi:10.1016/0092-8674(90)90669-6 · Cited by 460
Fission yeast chkl protein kinase links the rad checkpoint pathway to cdc2
Walworth, N. C., Davey, S. K., & Beach, D. (1993) · Nature · doi:10.1038/363368a0 · Cited by 455
Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation
O’Connell, M. J., Raleigh, J., Verkade, H. M., & Nurse, P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.3.545 · Cited by 398
rad -Dependent Response of the chk1 -Encoded Protein Kinase at the DNA Damage Checkpoint
Walworth, N. C., & Bernards, R. (1996) · Science · doi:10.1126/science.271.5247.353 · Cited by 397
Flagged first, then by citations
Research works printed but not linked: 3
- Waldman T., et al., ibid. 381, 713 (1996).
- Vorechovsky I., et al., Cancer Res. 56, 2726 (1996);
- Lakin N. D., et al., Oncogene 13, 2707 (1996).
Cited by
Sorted by citations
Items 901–1,000 of 1,000
KA1-targeted regulatory domain mutations activate Chk1 in the absence of DNA damage
Gong, E.-Y., Smits, V. A. J., Fumagallo-Reading, F., Piscitello, D., MORRICE, N. A., Freire, R., & Gillespie, D. A. (2015) · Scientific Reports · doi:10.1038/srep10856 · Cited by 16
Xue, L., Furusawa, Y., & Yu, D. S. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.07.001 · Cited by 15
KSR1 Is Required for Cell Cycle Reinitiation Following DNA Damage
Razidlo, G. L., Johnson, H. J., Stoeger, S. M., Cowan, K. H., Bessho, T., & Lewis, R. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806457200 · Cited by 15
Enhancement of Radiation Cytotoxicity by UCN-01 in Non-small Cell Lung Carcinoma Cells
Mack, P. C., Jones, A. A., Gustafsson, M. H., Gandara, D. R., Gumerlock, P. H., & Goldberg, Z. (2004) · Radiation Research · doi:10.1667/rr3253 · Cited by 15
Beardsley, D. I., Kim, W.-J., & Brown, K. D. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.013888 · Cited by 15
Analysis of fission yeast DNA structure checkpoints:1996 Fleming Lecture
Carr, A. M. (1998) · Microbiology · doi:10.1099/00221287-144-1-5 · Cited by 15
Cell Cycle Checkpoints as Therapeutic Targets
Stewart, Z. A., & Pietenpol, J. A. (1999) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018770417964 · Cited by 15
Yagi, Y., Teramoto, T., Kaieda, S., Imai, T., Sasaki, T., Yagi, M., Maekawa, N., & Nakamura, T. (2022) · Cells · doi:10.3390/cells11223529 · Cited by 15
Cryo-EM structure of the CDK2-cyclin A-CDC25A complex
Rowland, R. J., Korolchuk, S., Salamina, M., Tatum, N. J., Ault, J. R., Hart, S., Turkenburg, J. P., Blaza, J. N., Noble, M. E. M., & Endicott, J. (2024) · Nature Communications · doi:10.1038/s41467-024-51135-w · Cited by 14
Park, H.-J., Kim, S. H., & Moon, D. (2017) · Oncology Letters · doi:10.3892/ol.2017.6009 · Cited by 14
John, N. L., Joy, L. K., Kumar, M. S., Shaiju, S. S., Subashini, A., & Sajan, D. (2017) · Molecular Simulation · doi:10.1080/08927022.2017.1337272 · Cited by 14
Inhibitors of DNA double-strand break repair at the crossroads of cancer therapy and genome editing
Ray, U., & Raghavan, S. C. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114195 · Cited by 14
Cardiac regeneration: Pre-existing cardiomyocyte as the hub of novel signaling pathway
Wang, T., Chen, X., Wang, K., Ju, J., Yu, X. F., Yu, W., Liu, C.-Y., & Wang, Y. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.01.031 · Cited by 14
Filamin A stimulates cdc25C function and promotes entry into mitosis
Telles, E., Gurjar, M., Ganti, K., Gupta, D., & Dalal, S. N. (2011) · Cell Cycle · doi:10.4161/cc.10.5.14954 · Cited by 14
Dong, J.-Y., Wang, Z., Zou, P., Zhang, G., Dong, X., Ling, X., Zhang, X., Liu, J., Ye, D., Cao, J., et al. (2015) · Chemical Research in Toxicology · doi:10.1021/tx500489r · Cited by 14
Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3
Lian, X., Bao, C., Li, X., Zhang, X., Chen, H., Jung, Y., & Qian, Y. (2019) · Journal of Virology · doi:10.1128/jvi.02290-18 · Cited by 14
Differential response of normal and malignant urothelial cells to CHK1 and ATM inhibitors
Wang, W. T., Catto, J. W. F., & Meuth, M. (2014) · Oncogene · doi:10.1038/onc.2014.221 · Cited by 14
The DNA Damage‐Induced Cell Cycle Checkpoints
Widlak, P. (1999) · Computational and Mathematical Methods in Medicine · doi:10.1080/10273660008833051 · Cited by 14
Ashra, H., & Rao, K. V. K. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.05.044 · Cited by 14
Amino Acids C-Terminal to the 14-3-3 Binding Motif in CDC25B Affect the Efficiency of 14-3-3 Binding
Uchida, S., Kubo, A., Kizu, R., Nakagama, H., Matsunaga, T., Ishizaka, Y., & Yamashita, K. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj079 · Cited by 14
Zanghi, J. A., Mendoza, T. P., Knop, R. H., & Miller, W. M. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199811)177:2 · Cited by 26
Design and synthesis of a peptide derived from positions 195-244 of human cdc25C phosphatase
Morris, M. C., Méry, J., Heitz, A., Heitz, F., & Divita, G. (1999) · Journal of Peptide Science · doi:10.1002/(sici)1099-1387(199906)5:6 · Cited by 14
Fard, S. S., All‐Ericsson, C., & Hallböök, F. (2013) · Cell Cycle · doi:10.4161/cc.27200 · Cited by 13
Ferry, G., Studény, A., Bossard, C., Kubara, P. M., Zeyer, D., Renaud, J., Casara, P., Nanteuil, G. D., Wierzbicki, M., Pfeiffer, B., et al. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.06.010 · Cited by 13
Therapeutic potential of investigational CHK-1 inhibitors for the treatment of solid tumors
Babiker, H. M., McBride, A., Cooke, L. S., & Mahadevan, D. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1360275 · Cited by 13
Zhou, L., Pei, X., Zhang, Y., Ning, Y., Li, L., Hu, X., Chalasani, S. L., Sharma, K., Nkwocha, J., Yu, J., et al. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0366 · Cited by 14
Pereira, C., Arroyo-Martinez, G. A., Guo, M. Z., Downey, M. S., Kelly, E. R., Grive, K. J., Mahadevaiah, S. K., Sims, J. R., Faça, V. M., Tsai, C., et al. (2022) · eLife · doi:10.7554/elife.68677 · Cited by 13
Dong, M., Ouyang, Y., Gao, S.-C., Ma, X., Hou, Y., Schatten, H., Wang, Z., & Sun, Q. (2022) · Development · doi:10.1242/dev.200351 · Cited by 13
Mu, K., Li, L., Yang, Q., Zhang, T., Gao, P., Meng, B., Liu, Z., Wang, Y., & Zhou, G. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.03780.x · Cited by 13
de Sena-Tomás, C., Navarro‐González, M., Kües, U., & Pérez‐Martín, J. (2013) · Genetics · doi:10.1534/genetics.113.152231 · Cited by 13
Akiyama, M., Sowa, Y., Taniguchi, T., Watanabe, M., Yogosawa, S., Kitawaki, J., & Sakai, T. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x14850164661097 · Cited by 13
Mlody, B., Wruck, W., Martins, S., Sperling, K., & Adjaye, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-07905-2 · Cited by 13
He, G., Di, X., Yan, J., Zhu, C., Sun, X., & Zhang, S. (2018) · Cancer Science · doi:10.1111/cas.13810 · Cited by 13
Mori, H., Inoue, M., Yano, M., Wakabayashi, H., & Kido, H. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01126-1 · Cited by 13
Richardson, E., Stockwell, S. R., Li, H., Aherne, W., Cuomo, M. E., & Mittnacht, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031627 · Cited by 13
Mukherji, A., Janbandhu, V. C., & Kumar, V. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.02.068 · Cited by 13
Cauwenberge, A. V., & Alexandre, H. (2000) · The International Journal of Developmental Biology · doi:10.1387/ijdb.10949051 · Cited by 13
Targeting Molecular Signals in Chk1 Pathways as a New Approach for Overcoming Drug Resistance
Hapke, G., Yin, M.-B., & Rustum, Y. M. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013116826788 · Cited by 13
Bouché, J., Froment, C., Dozier, C., Esmenjaud, C., Lemaire, M., Monsarrat, B., Burlet‐Schiltz, O., & Ducommun, B. (2008) · Journal of Proteome Research · doi:10.1021/pr700623p · Cited by 13
Sugimoto, K., Tamayose, K., Takagi, M., Yamada, K., Sasaki, M., Mizutani, S., & Oshimi, K. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02304.x · Cited by 13
Uchida, Y., Ito, S., & Nukina, N. (2000) · Journal of Clinical Laboratory Analysis · doi:10.1002/1098-2825(20001212)14:6 · Cited by 12
Conservation of Eukaryotic DNA Repair Mechanisms
Lehmann, A. R., & Taylor, E. M. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-095-7_15 · Cited by 13
Barroso, E. C., Yance-Chávez, T., Kito, A., Sugiura, R., Gómez-Hierro, A., Giménez-Zaragoza, D., & Aligué, R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku684 · Cited by 12
Luna-Maldonado, F., Andonegui-Elguera, M. A., Díaz‐Chávez, J., & Herrera, L. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.700162 · Cited by 14
Interactions of HIV‐1 Viral Protein R with Host Cell Proteins
Zhao, Y., Elder, R. T., & Bukrinsky, M. (2007) · Advances in pharmacology · doi:10.1016/s1054-3589(07)55007-6 · Cited by 12
Varmeh, S., & Manfredi, J. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703105200 · Cited by 12
One pot synthesis of dibenzodiazepinones via CuI catalysis in ethylene glycol
Zhang, Q.-Y., Wang, X., Tian, Y., Qi, J., Li, C., & Yin, D. (2013) · Chinese Chemical Letters · doi:10.1016/j.cclet.2013.04.049 · Cited by 12
Matsumoto, Y., Shindo, Y., Takakusagi, Y., Takakusagi, K., Tsukuda, S., Kusayanagi, T., Sato, H., Kawabe, T., Sugawara, F., & Sakaguchi, K. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.10.004 · Cited by 12
A novelchk1-dependent G1/M checkpoint in fission yeast
Synnes, M., Nilssen, E. A., Boye, E., & Grallert, B. (2002) · Journal of Cell Science · doi:10.1242/jcs.00004 · Cited by 12
Shrestha, D., Choi, D., & Song, K. (2018) · Europe PMC (PubMed Central) · doi:10.14348/molcells.2018.2266 · Cited by 12
Jiang, K., Tong, L., Wang, T., Wang, H., Hu, X., Xu, G., Jin, T., Kan, W., Xu, L., Li, J., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00652-1 · Cited by 12
Markaverich, B. M., & Vijjeswarapu, M. (2012) · International Journal of Biomedical Science · doi:10.59566/ijbs.2012.8219 · Cited by 12
Slaninová, M., Nagyová, B., Gálová, E., Hendrychová, J., Bišová, K., Zachleder, V., & Vlček, D. (2003) · DNA repair · doi:10.1016/s1568-7864(03)00047-8 · Cited by 12
Activation of Xenopus Chk1 by mutagenesis of threonine‐377
Wang, S. X., & Dunphy, W. G. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02370-x · Cited by 12
Many faces of ATM: Eighth International Workshop on Ataxia-Telangiectasia
Halazonetis, T. D., & Shiloh, Y. (1999) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00023-2 · Cited by 12
Germ cell biology--from generation to generation
Donovan, P. J., Miguel, M. P. D., Hirano, M. P., Parsons, M. S., & Lincoln, A. J. (2001) · The International Journal of Developmental Biology · doi:10.1387/ijdb.11417895 · Cited by 12
Fujii, K., Miyashita, T., Takanashi, J., Sugita, K., Kohno, Y., Nishie, H., Yasumoto, S., Furue, M., & Yamada, M. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00719.x · Cited by 12
Morris, M. C., & Divita, G. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2475 · Cited by 12
Varmeh, S., & Manfredi, J. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0838 · Cited by 12
Takada, S., Collins, E. R., & Kurahashi, K. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-07-1238 · Cited by 11
Personalised Medicine: Genome Maintenance Lessons Learned from Studies in Yeast as a Model Organism
Abugable, A. A., Awwad, D. A., Fleifel, D., Ali, M. M., El‐Khamisy, S. F., & Elserafy, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-60733-7_9 · Cited by 11
Ariza, M. E., Bijur, G. N., & Williams, M. V. (1999) · Springer eBooks · doi:10.1007/978-1-4615-5153-9_5 · Cited by 11
Histone XH2AX Is Required for Xenopus Anterior Neural Development
Lee, S., Lau, A. T. Y., Jeong, C., Shim, J., Kim, H.-G., Kim, J., Bode, A. M., & Dong, Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127233 · Cited by 11
The Cdc25A is involved in S-phase checkpoint induced by benzo(a)pyrene
Yao, B., Fu, J., Hu, E., Qi, Y., & Zhou, Z. (2007) · Toxicology · doi:10.1016/j.tox.2007.05.015 · Cited by 11
Cancer Chemoprevention by Garlic - A Review
(2015) · Hereditary Genetics · doi:10.4172/2161-1041.1000147 · Cited by 11
Human DNA damage checkpoints and their relevance to soft tissue sarcoma
Hattori, H., Kuroda, M., Ishida, T., Shinmura, K., Nagai, S., Mukai, K., & Imakiire, A. (2003) · Pathology International · doi:10.1111/j.1440-1827.2004.01585.x · Cited by 11
Müller, A. M., Boitier, E., Hu, T., Carr, G. J., Fèvre, A.-C. L., Marchandeau, J.-P., Flor, M., Jefferson, F., Aardema, M. J., & Thybaud-Lambay, V. (2005) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20164 · Cited by 11
Figg, J., Barajas, J. M., & Obeng, E. A. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000632 · Cited by 10
WEE1 inhibitors trigger GCN2-mediated activation of the integrated stress response
Tjeerdsma, R. B., Ng, T. F., Roorda, M., Bianchi, D., Yang, S., Bonnet, C., VanInsberghe, M. A., Everts, M., Bakker, F. J., de Boer, H. R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66514-0 · Cited by 10
Zhang, Y., Luo, S., Jia, Y., & Zhang, X. (2022) · International Journal of Cancer · doi:10.1002/ijc.34007 · Cited by 10
Terhune, S. S., Jung, Y., Cataldo, K. M., & Dash, R. K. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007733 · Cited by 11
Thelestam, M., & Frisan, T. (2006) · Elsevier eBooks · doi:10.1016/b978-012088445-2/50028-7 · Cited by 10
Meise, R., Tomicic, M. T., Kaina, B., & Christmann, M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.008 · Cited by 11
Checkpoint Kinase and Wee1 Inhibitors as Anticancer Therapeutics
Ashwell, S. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-384999-1.10010-1 · Cited by 10
Deregulated Ras signaling compromises DNA damage checkpoint recovery in S. cerevisiae
Wood, M. D., & Sánchez, Y. (2010) · Cell Cycle · doi:10.4161/cc.9.16.12713 · Cited by 10
Burn Injury-Mediated Alterations in Cell Cycle Progression in Lymphoid Organs of Mice
Cho, K., Adamson, L. K., Park, J., & Greenhalgh, D. G. (2003) · Shock · doi:10.1097/00024382-200302000-00009 · Cited by 10
Nyberg, K. A., Michelson, R. J., Putnam, C. W., & Weinert, T. A. (2002) · Cited by 10
Nakamizo, A., Inamura, T., Inoha, S., Amano, T., Ochi, H., Ikezaki, K., & Fukui, M. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1016342013616 · Cited by 10
NOVEL TARGETS IN THE CELL CYCLE AND CELL CYCLE CHECKPOINTS
Pommier, Y. G., Yu, Q., & Kohn, K. W. (2002) · Elsevier eBooks · doi:10.1016/b978-012072651-6/50003-6 · Cited by 11
Rad24 is essential for proliferation of diploid cells in fission yeast
Tanaka, Y., Okuzaki, D., Yabuta, N., Yoneki, T., & Nojima, H. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01395-8 · Cited by 10
Hagihara, Y., Tomioka, Y., Suetsugu, T., Shinmura, M., Misono, S., Goto, Y., Kikkawa, N., Kato, M., Inoue, H., Mizuno, K., et al. (2023) · Cancers · doi:10.3390/cancers15235571 · Cited by 9
ATM and ATR checkpoint kinase pathways: A concise review
Chauhan, N., Wagh, V., Joshi, P., & Jariyal, H. (2020) · Advances in Human Biology · doi:10.4103/aihb.aihb_78_19 · Cited by 9
Kim, H., Seo, B., Seo, E.-C., Lee, K. M., & Hwangbo, C. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44120398 · Cited by 9
Wang, Q., ROSS, K. E., Huang, H., Ren, J. D., Li, G., Vijay‐Shanker, K., Wu, C. H., & Arighi, C. N. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6783-4_10 · Cited by 9
Liu, L., Li, S., Li, H., Yu, D., Li, C., Li, G., Cao, Y., Feng, C., & Deng, X. (2018) · Cell Biochemistry and Function · doi:10.1002/cbf.3334 · Cited by 9
Mitotic Arrest by Tumor Suppressor RASSF1A Is Regulated via CHK1 Phosphorylation
Jiang, L., Rong, R., Sheikh, M. S., & Huang, Y. K. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0482 · Cited by 9
Role for Metallothionein-3 in the Resistance of Human U87 Glioblastoma Cells to Temozolomide
Santangelo, R., Rizzarelli, E., & Copani, A. (2020) · ACS Omega · doi:10.1021/acsomega.9b04483 · Cited by 9
Famulski, K. S., & Paterson, M. C. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00664-x · Cited by 9
Targeting the Cell Cycle to Kill Cancer Cells
Taylor, W. R., & Grabovich, A. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369521-5.00017-8 · Cited by 9
Up-regulation of ANKDR49, a poor prognostic factor, regulates cell proliferation of gliomas
Hao, C., Duan, H., Li, H., Pei, M., Liu, Y., Fan, Y., & Zhang, C. (2017) · Bioscience Reports · doi:10.1042/bsr20170800 · Cited by 9
Sugimoto, K., Sasaki, M., Tamayose, K., & Oshimi, K. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01400.x · Cited by 9
Ejima, Y., & Yang, L. (1999) · Somatic Cell and Molecular Genetics · doi:10.1023/b:scam.0000007139.83021.fc · Cited by 9
Time as a danger signal promoting G1 arrest after mitosis
Fulcher, L. J., Batley, C., Sobajima, T., & Barr, F. A. (2025) · Trends in Cell Biology · doi:10.1016/j.tcb.2025.06.001 · Cited by 9
1-Methylxanthine enhances the radiosensitivity of tumor cells
Youn, H., Kook, Y. H., Oh, E., Jeong, S., Kim, C., Choi, E. K., Lim, B. U., & Park, H. J. (2009) · International Journal of Radiation Biology · doi:10.1080/09553000902741190 · Cited by 8
Hadaji, E., Goudzal, A., Aissouq, A. E., Chedadi, O., Hamdani, H. E., Ouammou, A., & Bouachrıne, M. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.133794 · Cited by 9
Cyclin-Dependent Kinases and Their Regulators as Potential Targets for Anticancer Therapeutics
Bronchud, M. H., Brizuela, L., Gyuris, J., & Mansuri, M. M. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-664-5_11 · Cited by 8
Caffeine does not enhance radiosensitivity of normal liver tissue in vivo
Wang, T., Liu, Z.-S., Zeng, Z., Du, S., Ming, Q., Jiang, W., Zhou, L., Ding, W., & Zeng, H. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0563-7 · Cited by 8
Wang, J., Zhang, Y., Xu, S., Li, W., Chen, Z., Wang, Z., Han, X., Zhao, Y., & Li, S. (2015) · Oncology Letters · doi:10.3892/ol.2015.2842 · Cited by 8
Rowley, R., & Zhang, J. (1999) · Genetics · doi:10.1093/genetics/152.1.61 · Cited by 8
Beyond VEGF: Targeting Tumor Growth and Angiogenesis via Alternative Mechanisms
Christensen, J. G., & Anderes, K. L. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-73898-7_4 · Cited by 8
Metadata
- Authors
- Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J.
- Affiliations
- Y. Sanchez, C. Wong, S. J. Elledge, Verna and Marrs McLean Department of Biochemistry, Department of Molecular and Human Genetics, Howard Hughes Medical Institute, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
- Howard Hughes Medical Institute (US)
- Venue
- Science
- Published
- 1997-09-05
- Volume
- 277
- Issue
- 5331
- Pages
- 1497-1501
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2105592350
- Cited by
- 1,320
- References
- 24
- Citations by year
- 2026: 11 · 2025: 20 · 2024: 14 · 2023: 32 · 2022: 29 · 2021: 25 · 2020: 30 · 2019: 22 · 2018: 22 · 2017: 35 · 2016: 34 · 2015: 39 · 2014: 29 · 2013: 37 · 2012: 39
- FWCI
- 30.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1f32gm017763-01)
- National Institute of General Medical Sciences (GM-44664, GM17763)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- Chk1, DNA damage checkpoint, Cdc25 phosphatase, cyclin-dependent kinases, cell cycle regulation, 14-3-3 protein binding, mitotic entry, protein kinases, mammalian cells
- MeSH terms
- Checkpoint Kinase 1, F-Box-WD Repeat-Containing Protein 7, Amino Acid Sequence, Animals, Chromosome Mapping, Chromosomes, Human, Pair 11, Cytoskeletal Proteins, DNA Damage, HeLa Cells, Humans, Mitosis, Molecular Sequence Data, Phosphoprotein Phosphatases, Phosphorylation, Phosphoserine, Protein Kinases, Proteins, Recombinant Fusion Proteins, Transfection, Tyrosine 3-Monooxygenase, Signal Transduction, G2 Phase, CDC2 Protein Kinase, Protein Tyrosine Phosphatases, Cell Cycle Proteins, cdc25 Phosphatases, Schizosaccharomyces pombe Proteins, Ubiquitin-Protein Ligases, F-Box Proteins, 14-3-3 Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review